Where is Quantum Pharmaceuticals headquartered?

Quantum Biopharma is recorded with headquarters in Moscow, CA in NovaPharmaNews public regulatory and sponsor datasets.

Is Quantum Pharmaceuticals publicly traded?

Yes — Quantum Pharmaceuticals is listed as a public company with ticker QNTM on NYSE in SEC EDGAR-derived records.

What drugs are associated with Quantum Pharmaceuticals?

We link 8 drug profile(s) where Quantum Pharmaceuticals appears as originator or marketer in FDA or regional approval metadata.

What clinical trials is Quantum Pharmaceuticals sponsoring?

Quantum Pharmaceuticals is linked to 18 pipeline program(s) sourced from ClinicalTrials.gov and EU CTIS where sponsor names match.

What patents list Quantum Pharmaceuticals as applicant?

36 USPTO PatentsView record(s) name Quantum Biopharma or a normalized variant as applicant.

What pipeline phases does Quantum Pharmaceuticals have in our database?

Phase distribution from linked programs: phase 2: 7, phase 1: 6, phase 3: 2.

How many US-approved drugs are linked to Quantum Pharmaceuticals?

8 linked drug profile(s) include US approval status in openFDA-derived metadata.

Where does NovaPharmaNews source data on Quantum Pharmaceuticals?

Profiles combine SEC EDGAR (US issuers), FDA openFDA, EMA medicines data, ClinicalTrials.gov, EU CTIS, USPTO PatentsView, and regional PBS/PMDA/NMPA feeds. See /about/data-sources.

Is Quantum Pharmaceuticals data investment advice?

No. This profile is compiled from public regulatory records for professional reference only, not investment or medical advice.

Is Quantum Pharmaceuticals data investment advice?

No. This profile is compiled from public regulatory records for professional reference only, not investment or medical advice.

Quantum Pharmaceuticals Pharmaceuticals Company Profile

Name: Quantum Pharmaceuticals intelligence dataset
Creator: NovaPharmaNews
License: https://www.sec.gov/edgar.shtml

Company details

Status: Public
HQ: volkova 6A-1206, Moscow, 141700, RU, CA
Founded: 2004
Employees: 29
Programs: 18
Drugs: 17
Patents: 36

Official website ↗ All projects Drug pipeline Patents News & analysis

Quick answer

Quantum Pharmaceuticals is a biotech organization headquartered in Moscow, CA. It trades on NYSE under ticker QNTM. Primary therapeutic focus areas include Hypertension, Essential Hypertension, Breast Cancer, Metastatic Breast Cancer, Hypertension (HTN). NovaPharmaNews links 18 clinical program(s), 8 drug profile(s), and 36 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (7), phase 1 (6), phase 3 (2).

Company snapshot

Quantum Pharmaceuticals is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services and pursue in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and oncological efficacy.

8 approved product(s) across US/EU regulatory metadata.
18 active pipeline program(s) linked via ClinicalTrials.gov.
36 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Quantum Pharmaceuticals. Not investment advice.

Top assets

View drugs (17) View projects (18)

Lead pipeline drugs

alcohol
approved
anti-
Marketed / approved
benztropine mesylate
approved
clorazepate dipotassium
approved

Active clinical programs

Firibastat Hypertension
Phase 3
Firibastat (QGC001) Period 1 Hypertension (HTN)
Phase 3
Dendritic Cell Vaccination Breast Cancer
Phase 2
FSD201 COVID-19
Phase 2

Momentum

Proprietary activity score for Quantum Pharmaceuticals.

1 active signal

20 /100 +0 vs 30 days ago

Signal breakdown

Clinical trials 19 30d
Nova articles 0 30d
Patents filed 0 30d
FDA actions 0 30d
SEC filings 0 30d
Conference presentations 0 90d
Pipeline advances 0 30d

Competitor landscape

Therapeutic-area overlap peers from registry and pipeline signals.

Peer + 0 momentum

United Therapeutics Europe

TA overlap score 40
Peer + 0 momentum

Chinese Academy of

TA overlap score 40
Peer + 0 momentum

First People's Hospital

TA overlap score 40
Peer + 0 momentum

Pfizer

TA overlap score 39.6
Peer + 0 momentum

Rhythm Pharmaceuticals Netherlands

TA overlap score 34.6
Peer + 0 momentum

Eli Lilly and

TA overlap score 32.4
Peer + 0 momentum

Chinese University of

TA overlap score 28.4
Peer + 0 momentum

LIGAND PHARMACEUTICALS

TA overlap score 26.8
Peer + 0 momentum

Oncolytics Biotech

TA overlap score 24.6
Peer + 0 momentum

WINDTREE THERAPEUTICS INC

TA overlap score 23

Recent activity

Latest pipeline, patent, and corporate events for Quantum Pharmaceuticals.

Jun 8, 2026 Clinical update
QGC001/1QG2 — Phase 1
Jun 8, 2026 Clinical update
Ramipril — Phase 2
Jun 8, 2026 Clinical update
FSD201 — Phase 2
Jun 5, 2026 Clinical update
Symbiotic Formula with DHA and antioxidants — Unknown
Jun 5, 2026 Clinical update
FSD201 — Phase 2

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

What is Quantum Pharmaceuticals?

Quantum Pharmaceuticals is a biotech organization headquartered in Moscow, CA. It trades on NYSE under ticker QNTM. Primary therapeutic focus areas include Hypertension, Essential Hypertension, Breast Cancer, Metastatic Breast Cancer, Hypertension (HTN). NovaPharmaNews links 18 c
Is Quantum Pharmaceuticals publicly traded?

Yes. Quantum Pharmaceuticals is listed with ticker QNTM on NYSE per SEC EDGAR records linked on this profile.
What drugs does Quantum Pharmaceuticals develop or market?

We link 17 drug profile(s) where Quantum Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/quantum-biopharma#company-drugs.
What are the latest developments for Quantum Pharmaceuticals?

In the last 12 months our linked public records show 18 trial program update(s) and 4 US patent grant(s) tied to this profile.
What therapeutic areas does Quantum Pharmaceuticals focus on?

Quantum Pharmaceuticals focuses on Hypertension, Essential Hypertension, Breast Cancer based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others

Cardiology

Oncology

Infectious Disease